Page not found

Search results

  1. Innovation Catalyst Fund announces eight inaugural awardees; next round submission deadline is April 15

    ... Cybele Raver and Vice Chancellor for Finance and Information Technology Brett Sweet, received 24 submissions and will provide pre-seed ... to be refined for potential resubmission. The Center for Technology Transfer and Commercialization manages the proposal submission and ...

    sommers - 02/13/2024 - 10:43am

  2. Small Molecule-GIRK Potassium Channel Modulators That Are Anxiolytic Therapeutics

    ... While the group is using ML297 to continue to explore the therapeutic benefits of GIRK modulation, they are continuing to develop more ... of animals tested that experienced convulsions from PTZ treatment and in (c) the percentage of animals that survived PTZ treatment. In ...

    cttc_admin - 01/23/2024 - 1:38pm

  3. Applications now open for ASPIRE postdoctoral research fellowship to support path to entrepreneurship

    ... structured training opportunity to learn how to transform a technology into a company A biomedical sciences postdoc will be hired to ... to develop a commercialization strategy on a particular technology while immersing themselves in the local bioscience entrepreneurial ...

    sommers - 02/07/2024 - 10:47am

  4. “Ultra-potent” antibody against COVID-19 variants isolated at VUMC

    09/27/2021 A technology developed at Vanderbilt University Medical Center has led to the ... addition to the limited set of broadly reactive antibody therapeutic candidates, researchers reported  Sept. 15  in the journal  Cell Reports . The technology, called LIBRA-seq, has helped speed up the discovery of antibodies ...

    sommers - 09/28/2021 - 9:45am

  5. Lessons learned from 2015 BIO conference

    ... What we heard from industry when showcasing Vanderbilt’s therapeutic programs After meeting with 30+ companies in one on one ... the 7,000 rare diseases identified, only 289 have approved treatment options available. While still risky, interest is ...

    machinm - 10/02/2015 - 10:43am

  6. Study shows new COVID target could improve vaccines

    ... University School of Medicine in St. Louis, Missouri. Treatment and prevention may be more effective if multiple antigenic sites on ... virus. Adding NTD-recognizing monoclonal antibodies to therapeutic antibody cocktails could minimize the selection of “escape ...

    sommers - 04/12/2021 - 10:52am

  7. Widely used software, developed by Young Lab, tops 1,000 academic licenses

    ... normal conditions versus in response to a disease, drug treatment, or a genetic change in the cells’ DNA,” Young said. ... said Masood Ahammed Machingal, manager, digital technology licensing Building on the successes of non-patented intellectual ...

    sommers - 05/03/2021 - 10:24am

  8. Chikungunya antibody identified at VUMC moves forward

    ... believe it holds great promise to be become an effective therapeutic and prophylactic treatment option and is thus expected to make a real difference for people ...

    sommers - 03/08/2021 - 8:29am

  9. Tech Connect, Vol. 7, Issue 7: CTTC welcomes UASP Fellow Tonny Omwansa

    ... of Nairobi. Tonny discussed innovation, entrepreneurship and technology transfer best practices with CTTC Licensing Officers and New ... a small pharmaceutical company for technology related to a therapeutic approach to treat demyelinating diseases developed by Jun Li and Bo ...

    steelmk - 11/10/2016 - 7:45am

  10. VUMC Licensee Evotec Starts Clinical Development of Chikungunya Antibody

    ... development to identify an investigational product with both therapeutic and prophylactic potential that has now entered Phase I. At a ... to be become an effective therapeutic and prophylactic treatment option and is thus expected to make a real difference for people ...

    sommers - 01/29/2021 - 8:45am